$ICON continues to impress me. :) Iconix Brand Group

New Post Public Reply Private Reply Replies (1) Message Board
Bible Feed

$ICON continues to impress me.

Iconix Brand Group Reports Revenue And Earnings For The Second Quarter 2012

NEW YORK , July 25, 2012 /PRNewswire/ --

  • Q2 non-GAAP diluted EPS of $0.45 compared to $0.43 in prior year quarter
  • Q2 revenue of $93.6 million , a 5% increase over prior year quarter
  • Q2 EBITDA of $58.4 million and EBITDA margins of 62%
  • Q2 Free Cash Flow of $51.9 million , an 11% increase over prior year quarter

Iconix Brand Group, Inc. (NASDAQ: ICON) ("Iconix" or the "Company"), today announced financial results for the second quarter ended June 30, 2012 .

Q2 2012 results for Iconix Brand Group, Inc.:

Total revenue for the second quarter of 2012 was approximately $93.6 million , a 5% increase as compared to approximately $89.3 million in the second quarter of 2011. Total revenue includes approximately $5.6 million related to the completion of the Company's new joint venture in India . On a non-GAAP basis, as defined in the tables below, net income attributable to Iconix for the second quarter was approximately $32.4 million , as compared to approximately $32.3 million the prior year quarter. Non-GAAP diluted EPS for the second quarter was $0.45 compared to $0.43 in the prior year quarter. EBITDA attributable to Iconix for the second quarter was approximately $58.4 million , as compared to approximately $58.1 million in the prior year quarter. Free cash flow attributable to Iconix for the second quarter was approximately $51.9 million , an 11% increase over the prior year quarter.

GAAP net income attributable to Iconix and diluted EPS in the second quarter of 2011 included a non-cash, non-recurring gain of approximately $21.5 million related to the Company's acquisition of the global master license of the Ed Hardy brand.  GAAP net income attributable to Iconix for the second quarter was approximately $28.6 million , as compared to $41.5 million in the prior year quarter and GAAP diluted EPS was $0.40 compared to $0.55 in the prior year quarter.

Six months ended June 30, 2012 :

Total revenue for the six months ended June 30, 2012 was approximately $182.1 million , as compared to approximately $181.6 million for the prior year period. EBITDA attributable to Iconix for the six month period was approximately $115.2 million as compared to approximately $116.9 million in the prior year period. Free cash flow attributable to Iconix for the six month period was approximately $99.4 million , a 7% increase over the prior year period. On a non-GAAP basis, as defined in the tables below, net income attributable to Iconix for the six month period was approximately $64.4 million as compared to approximately $66.1 million in the prior year period, and non-GAAP diluted earnings per share was approximately $0.88 for the six month period versus $0.88 for the prior year period.

As mentioned above, GAAP net income attributable to Iconix and diluted EPS for the prior period included a non-cash, non-recurring gain of approximately $21.5 million .  On a GAAP basis, net income attributable to Iconix was approximately $56.2 million as compared to $73.0 million in the prior year period and GAAP diluted earnings per share was $0.76 versus $0.97 for the prior year period.

EBITDA, free cash flow, non-GAAP net income and non-GAAP EPS are all non-GAAP metrics and reconciliation tables to the respective GAAP measures are attached to this press release.

Neil Cole , Chairman and CEO of Iconix Brand Group, Inc. commented, "We are pleased with our overall performance in the second quarter. Our strategy of building our brands globally is gaining momentum with the launch of our India joint venture with Reliance and our first two direct-to-retail licenses in Europe . Looking ahead, we see continued opportunities to grow the portfolio both in the U.S. and around the world. In addition, with our significant free cash flow and strong balance sheet we plan to continue to deliver increased shareholder value through acquisitions and share repurchase."

2012 Guidance for Iconix Brand Group, Inc.:

The Company is reaffirming its full year 2012 revenue guidance of $340 to $350 million , its 2012 non-GAAP diluted EPS guidance of $1.65 to $1.74 , its 2012 GAAP diluted EPS guidance of $1.48-$1.57 , and its 2012 free cash flow guidance of $174 to $181 million .  This guidance relates to the existing portfolio of brands and does not include any additional acquisitions.

See reconciliation tables below for non-GAAP metrics. These non-GAAP metrics may be inconsistent with similar measures presented by other companies and should only be used in conjunction with our results reported according to U.S. GAAP.  Any financial measure other than those prepared in accordance with U.S. GAAP should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP.

About Iconix Brand Group, Inc.

Iconix Brand Group, Inc. owns, licenses and markets a growing portfolio of consumer brands including: CANDIE'S (R), BONGO (R), BADGLEY MISCHKA (R), JOE BOXER (R), RAMPAGE (R), MUDD (R), MOSSIMO (R), LONDON FOG (R), OCEAN PACIFIC (R), DANSKIN (R), ROCAWEAR (R), CANNON (R), ROYAL VELVET (R), FIELDCREST (R), CHARISMA (R), STARTER (R), WAVERLY (R), ZOO YORK (R), and SHARPER IMAGE (R).  In addition, Iconix owns interests in the ARTFUL DODGER (R), ECKO (R), MARC ECKO (R), ED HARDY (R) MATERIAL GIRL (R), PEANUTS (R), and TRUTH OR DARE brands. The Company licenses its brands to a network of leading retailers and manufacturers that touch every major segment of retail distribution from the luxury market to the mass market in both the U.S. and worldwide. Through its in-house business development, merchandising, advertising and public relations departments Iconix manages its brands to drive greater consumer awareness and equity.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this press release are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond the control of the Company, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Such factors include, but are not limited to, uncertainty regarding the results of the Company's acquisition of additional licenses, continued market acceptance of current products and the ability to successfully develop and market new products particularly in light of rapidly changing fashion trends, the impact of supply and manufacturing constraints or difficulties relating to the Company's licensees' dependence on foreign manufacturers and suppliers, uncertainties relating to customer plans and commitments, the ability of licensees to successfully market and sell branded products, competition, uncertainties relating to economic conditions in the markets in which the Company operates, the ability to hire and retain key personnel, the ability to obtain capital if required, the risks of litigation and regulatory proceedings, the risks of uncertainty of trademark protection, the uncertainty of marketing and licensing acquired trademarks and other risks detailed in the Company's SEC filings. The words "believe", "anticipate", "estimate", "expect", "confident", "continue", "will", "project", "provide" "guidance" and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward looking statements, which speak only as of the date the statement was made. All forward-looking statements are qualified by these cautionary statements and apply only as of the date they are made. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact Information:
Jaime Sheinheit
Investor Relations
Iconix Brand Group
212.730.0030

http://www.iconixbrand.com/invest_fin_rel.html

Iconix Brand Group (ICON) Stock Research Links

ICON Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Magna5 Secures 39th Spot on Inc.'s Prestigious Rankings

Updated Category News Views 245

Magna5 Achieves Recognition in Inc. Rankings In a proud moment for the team, Magna5 has ranked No. 39 on the coveted Inc. Regionals: Northeast list. This annual evaluation highlights the fastest-growing private companies within this region, emphasizing the remarkable impact of independent small businesses in various sectors. The company’s recognition showcases its...

Continue Reading
Appian Shines as a Leader in Process Orchestration Assessment

Updated Category News Views 236

Appian Recognized as a Leader in Process Orchestration Appian has made headlines recently by being named a leader in a prominent assessment of process orchestration products. This recognition by Everest Group positions Appian at the forefront of innovations that empower businesses to enhance their operational workflows and increase efficiency. What Is Process...

Continue Reading
Financial Institutions Reports Strong EPS Beat, Price Target Held

Updated Category News Views 195

Analysis of Financial Institutions’ Recent Performance Recently, Financial Institutions (NASDAQ:FISI) received an Equal Weight rating from Stephens, reaffirming a price target of $28.50. The company delivered impressive financial results, with earnings per share (EPS) reported at $0.84 for GAAP and $0.82 for operating earnings. These figures exceeded both the company's...

Continue Reading
United Airlines Earnings Preview: Analyst Upgrades and Insights

Updated Category News Views 168

United Airlines Earnings Report Overview United Airlines Holdings, Inc. (NASDAQ: UAL) is on the brink of announcing its third-quarter earnings results. Investors and analysts alike are eagerly anticipating these numbers, especially as the company is projected to report a decrease in earnings per share compared to the previous year. Expected Earnings Decline Analysts...

Continue Reading
Ontex's Strategic Share Buyback Program Overview

Updated Category News Views 114

Ontex's Strategic Share Buyback Program Ontex is making headlines with its ongoing program to acquire treasury shares, which marks a significant move for the company. The decision to initiate this buyback was formally disclosed in accordance with the regulations established by the Belgian government. This proactive strategy is designed to enhance shareholder value and...

Continue Reading